Research and data: Hannah Ritchie, Esteban Ortiz-Ospina, Diana Beltekian, Edouard Mathieu, Joe Hasell, Bobbie Macdonald, Charlie Giattino, and Max Roser
Web development: Breck Yunits, Ernst van Woerden, Daniel Gavrilov, Matthieu Bergel, Shahid Ahmad, and Jason Crawford
- Coronavirus
- By country
- Data explorer
- Deaths
- Cases
- Tests
- Hospitalizations
- Vaccinations
- Mortality risk
- Excess mortality
- Policy responses
- Exemplars
- All charts
How many people have received the coronavirus vaccine?
Tracking COVID-19 vaccination rates is crucial to understand the scale of protection against the virus, and how this is distributed across the global population.
A global, aggregated database on COVID-19 vaccination rates is essential to monitor progress, but it is unfortunately not yet available. When a global, or aggregated regional database — such as European data collated by the European CDC — becomes available, Our World in Data will provide these weekly updates of vaccination rates, presented in our interactive COVID-19 Explorer, and our Complete COVID-19 Dataset.
Until such a database is made available, Our World in Data will be tracking recent announcements on the first countries to administer these vaccinations.
The first approved COVID-19 vaccine was administered in the United Kingdom on December 8th 2020. Note that other countries have also started vaccination campaigns—we’ll add them to our maps and charts as soon as numbers are published on official websites, in press releases, or by social media accounts of national authorities. We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.
The following map and chart show the number of COVID-19 vaccination doses administered per 100 people within a given population. Note that this does not measure the total number of people that have been vaccinated (which is usually two doses).Number of COVID-19 vaccination doses administered per 100 people
Shown is the total number of COVID-19 vaccinations administered per 100 people. This is counted as a single
vaccination dose, and does not measure the number of people vaccinated against the disease (which usually requires
two doses).
No data00.10.20.30.40.5WorldCC BY
Source: Official data collated by Our World in Data
Number of COVID-19 vaccination doses administered per 100 people
Shown is the total number of COVID-19 vaccinations administered per 100 people. This is counted as a single
vaccination dose, and does not measure the number of people vaccinated against the disease (which usually requires
two doses).
- Add country
00.050.10.150.20.250.3Scotland0.33Wales0.25Northern Ireland0.21United Kingdom0.2England0.19World<0.01CC BY
Source: Official data collated by Our World in Data
Total number of COVID-19 vaccinations administered
The following map and chart show the total number of COVID-19 vaccination doses administered. Note that this does not measure the total number of people that have been vaccinated (which is usually two doses).Number of COVID-19 vaccination doses administered, Dec 16, 2020
Shown is the total number of COVID-19 vaccinations administered. This is counted as a single vaccination dose, and
does not measure the number of people vaccinated against the disease (which usually requires two doses).
No data010,000100,0001 million10 million100 million1 billionWorldCC BY
Source: Official data collated by Our World in Data
Number of COVID-19 vaccination doses administered, Dec 16, 2020
Shown is the total number of COVID-19 vaccinations administered. This is counted as a single vaccination dose, and
does not measure the number of people vaccinated against the disease (which usually requires two doses).
- Add country
020,00040,00060,00080,000100,000120,000United Kingdom137,897World137,897England108,000Scotland18,000Wales7,897Northern Ireland4,000CC BY
Source: Official data collated by Our World in Data
Vaccination policies
COVID-19 Vaccination Policy, Dec 16, 2020
This metric records policies for vaccine delivery for different groups.
– Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
– Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
– Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
– Availability for all three plus partial additional availability (select broad groups/ages)
– Universal availability
No dataNoneOne groupTwo groupsAll vulnerable groupsVulnerable + some othersUniversalWorld
Source: Hale, Webster, Petherick, Phillips, and Kira (2020). Oxford COVID-19 Government Response Tracker – Last updated 16 December, 17:01
(London time)
CC BYJan 1, 2020Dec 16, 2020
This interactive chart maps government policies on COVID-19 vaccination. Note that this only tracks policies on the availability of vaccinations. It does not track the number of people who have been vaccinated.
Countries are grouped into six categories:
- No availability
- Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
- Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
- Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
- Availability for all three plus partial additional availability (select broad groups/ages)
- Universal availability
Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker
This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).
This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.
The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.
The data presented here is taken directly from the OxCGRT project; Our World in Data do not track policy responses ourselves, and do not make additions to the tracker dataset.
These charts are regularly updated based on the latest version of the response tracker.
OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.
Vaccine development: vaccines approved for use and in clinical trials
The speed at which the first COVID-19 vaccines were developed was extraordinary. We have previously looked into the history of vaccine development. The measles vaccine was found relatively rapidly: it took only 10 years from the discovery of the pathogen to the development of the first vaccine. But for typhoid it took more than a century, and for some diseases for which we’ve known the pathogens for more than a century (like malaria) we still haven’t found an effective vaccine.
The development of a vaccine against COVID-19 has been much faster than the development of any other vaccine. Within less than a year several successful vaccines have already been announced and were approved for use in some countries.
The hope is that even more manufacturers develop vaccines for COVID-19. This will be important because eventually a very large share of the world population needs to receive a COVID-19 vaccine.
We are on the way to several vaccines against COVID-19 – vaccine trackers monitor the progress:
Several institutions maintain websites on which they list COVID-19 candidate vaccines that are currently being developed. The London School of Hygiene & Tropical Medicine Vaccine Tracker is embedded here – it is updated weekly and shows the current stage of each development.
Other institutions which track the latest COVID-19 candidate vaccines include:
- WHO Vaccine Tracker – The WHO is tracking the COVID-19 candidate vaccines that are under development.
- Milken Institute Vaccine Tracker – The Milken Institute publishes, and regularly updates a tracker of possible treatments and vaccines for COVID-19 that scientists are currently working on.
- New York Times – The NYT tracker includes brief summaries of each development.
source: ourworldindata